Scarica l'app Stockscreener
2.75
4.84%
-0.14
Pre-mercato:
2.75
Sutro Biopharma Inc Azioni (STRO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
88.56%
13.01
|
113.72 | 16.92 | 10.41 | 12.67 |
Operating Expenses
|
1.37%
69.60
|
70.57 | 60.94 | 56.59 | 54.91 |
| Benefits Costs and Expenses |
6.54%
71.22
|
66.85 | 64.37 | 48.78 | 62.33 |
| Costs And Expenses |
6.54%
71.22
|
66.85 | 64.37 | 48.78 | 62.33 |
| Operating Income/Loss |
231.14%
-56.59
|
43.15 | -44.01 | -46.18 | -42.24 |
| Income/Loss From Continuing Operations Before Tax |
224.20%
-58.21
|
46.87 | -47.45 | -38.37 | -49.66 |
| Income/Loss From Continuing Operations After Tax |
287.39%
-58.21
|
31.07 | -49.28 | -38.52 | -50.05 |
|
Net Income/Loss
|
287.39%
-58.21
|
31.07 | -49.28 | -38.52 | -50.05 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
22,716%
61.46
|
0.2694 | 60.60 | 60.34 | 58.72 |
| Diluted Average Shares |
22,716%
61.46
|
0.2694 | 60.60 | 60.34 | 58.72 |
| Basic Earnings Per Share |
282.69%
-0.95
|
0.52 | -0.81 | -0.64 | -0.85 |
| Diluted Earnings Per Share |
282.69%
-0.95
|
0.52 | -0.81 | -0.64 | -0.85 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):